captopril has been researched along with fibrin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galluzzo, TS; Gardner, DV; Molteni, A; Ts'ao, C | 1 |
| Fogo, A; Freeman, M; Lo, W; Oikawa, T; Vaughan, DE | 1 |
| Hiraoka, Y; Kishimoto, C; Kurokawa, M; Sasayama, S; Shiraki, K; Takada, H | 1 |
| Buczko, W; Chabielska, E; Domaniewski, T; Karp, A; Kramkowski, K; Malinowska-Zaprzałka, M; Mogielnicki, A; Opadczuk, A; Wojewódzka-Zelezniakowicz, M | 1 |
4 other study(ies) available for captopril and fibrin
| Article | Year |
|---|---|
Effect of captopril, MK-421 and MK-422 on fibrinolysis determined by 3 "in vitro" assays.
Topics: Animals; Captopril; Cattle; Dipeptides; Enalapril; Enalaprilat; Fibrin; Fibrinolysin; Fibrinolysis; Humans; In Vitro Techniques; Proline | 1984 |
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cytokines; Enalapril; Fibrin; Fibrinolysin; Fibrosis; Gene Expression Regulation, Enzymologic; Growth Substances; Imidazoles; In Situ Hybridization; Kidney; Male; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Tetrazoles; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 1997 |
Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis.
Topics: Animals; Captopril; Chlorocebus aethiops; Connective Tissue; Coxsackievirus Infections; Enterovirus B, Human; Extracellular Space; Fibrin; Myocarditis; Myocardium; Myosins; Organ Size | 1997 |
Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Disease Models, Animal; Enalapril; Fibrillar Collagens; Fibrin; Hemostasis; Male; Perindopril; Platelet Adhesiveness; Platelet Aggregation; Quinapril; Rats; Rats, Wistar; Regional Blood Flow; Tetrahydroisoquinolines; Thromboembolism | 2006 |